Creative Financial Designs Inc Abbott Laboratories Transaction History

Creative Financial Designs Inc

$1.2 Billion
Q4 2024

A detailed history of Creative Financial Designs Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Creative Financial Designs Inc holds 1,531 shares of ABT stock, worth $199,305. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,531

Previous 1,539 0.52%

Holding current value

$199,305

Previous $175,000 1.14%

% of portfolio

0.01%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$111.93 - $119.39 $895 - $955	-8 Reduced 0.52%	1,531 $173,000
Q3 2024 Oct 28, 2024	SELL	$100.07 - $118.13 $5,804 - $6,851	-58 Reduced 3.63%	1,539 $175,000
Q2 2024 Aug 06, 2024	BUY	$100.73 - $112.44 $6,245 - $6,971	62 Added 4.04%	1,597 $165,000
Q1 2024 May 01, 2024	BUY	$109.52 - $120.96 $4,599 - $5,080	42 Added 2.81%	1,535 $174,000
Q4 2023 Jan 10, 2024	SELL	$90.19 - $110.4 $12,806 - $15,676	-142 Reduced 8.69%	1,493 $164,000
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $4,489 - $5,387	47 Added 2.96%	1,635 $158,000
Q2 2023 Jul 26, 2023	BUY	$100.78 - $112.29 $24,892 - $27,735	247 Added 18.42%	1,588 $173,000
Q1 2023 Apr 25, 2023	SELL	$96.86 - $114.01 $6,489 - $7,638	-67 Reduced 4.76%	1,341 $135,000
Q4 2022 Feb 01, 2023	SELL	$95.06 - $111.52 $30,799 - $36,132	-324 Reduced 18.71%	1,408 $154,000
Q3 2022 Nov 01, 2022	BUY	$96.76 - $112.03 $96 - $112	1 Added 0.06%	1,732 $168,000
Q2 2022 Aug 01, 2022	SELL	$102.07 - $123.37 $40,113 - $48,484	-393 Reduced 18.5%	1,731 $188,000
Q1 2022 Apr 15, 2022	SELL	$114.02 - $139.04 $1,596 - $1,946	-14 Reduced 0.65%	2,124 $251,000
Q4 2021 Jan 26, 2022	BUY	$115.53 - $141.46 $51,179 - $62,666	443 Added 26.14%	2,138 $301,000
Q2 2021 Jul 27, 2021	BUY	$105.79 - $124.53 $30,044 - $35,366	284 Added 20.13%	1,695 $197,000
Q1 2021 Apr 19, 2021	BUY	$108.84 - $128.23 $8,816 - $10,386	81 Added 6.09%	1,411 $169,000
Q4 2020 Jan 08, 2021	SELL	$105.0 - $114.42 $6,510 - $7,094	-62 Reduced 4.45%	1,330 $146,000
Q3 2020 Oct 06, 2020	BUY	$91.64 - $111.29 $46,644 - $56,646	509 Added 57.64%	1,392 $151,000
Q2 2020 Jul 23, 2020	BUY	$76.57 - $98.0 $67,611 - $86,534	883 New	883 $81,000
Q3 2018 Nov 02, 2018	SELL	$60.81 - $73.36 $30,405 - $36,680	-500 Closed	0 $0
Q2 2018 Jul 13, 2018	SELL	$57.57 - $63.54 $23,028 - $25,416	-400 Reduced 44.44%	500 $30,000
Q1 2018 May 02, 2018	BUY	$56.27 - $63.62 $28,135 - $31,810	500 Added 125.0%	900 $54,000
Q4 2017 May 02, 2018	BUY	$53.68 - $57.47 $14,869 - $15,919	277 Added 225.2%	400 $23,000
Q2 2017 May 02, 2018	SELL	N/A	-273 Reduced 68.94%	123 $6,000
Q1 2017 May 02, 2018	SELL	N/A	-886 Reduced 69.11%	396 $18,000
Q4 2016 Mar 14, 2018	BUY	N/A	1,282	1,282 $49,000

Others Institutions Holding ABT

# of Institutions

3,352

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

News

Stay updated on Creative Financial Designs Inc with notifications on news.

Account

Creative Financial Designs Inc Abbott Laboratories Transaction History